Validation of an Allergic Rhinitis Control Test in Children
ConditionAllergic Rhinitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-11
SponsorUniversity Hospital, Montpellier
About this trial
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
Parents formulated their study participation agreement by signing the consent form.
Disqualifiers
Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.
Trial design
Design model
Single group
Treatments tested in this trial
Self Questionnaire
Other interventionself questionnaire for allergic rhinitis control
Treatment groups
135 Participants
are divided into 1 treatment groupGroup A: ExperimentalExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Score of the allergic rhinitis control self questionnaire
Score of the allergic rhinitis control self questionnaire in teenagers from 5 to 11 years old.
Time frame
15 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov